Health Condition 1: J329- Chronic sinusitis, unspecified
Conditions
Interventions
Intervention1: Itrifal Ustukhuddus: Patients will be given compound test drug that has to be administered orally after meals in a dosage of 7gm for 6 weeks.
Control Intervention1: Sharbat e Sadar: Pat
Sponsors
State Unani Medical College
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of any sex, aged 18-50 years 2. Duration of the disease greater than 12 week. 3. Patient having at least two out of four cardinal symptoms i.e., facial pain/pressure, hyposmia/anosmia, nasal obstruction, and nasal discharge for at least 12 consecutive weeks 4. Patient having any of the following symptoms like rhinorrhoea, nasal congestion, frontal headache, nasal itching, impaired sense of smell and frequent sneezing for more than 12 weeks. 5. Positive X-ray PNS finding like Thickened mucosal lining, opacity of sinus.
Exclusion criteria
Exclusion criteria: 1. Patient aged below 18 years or above 50 years 2. Patient with deviated nasal septum 3. Local pathology such as mucocele, cyst, antrochoanal polyp, facial trauma. 4. Diabetes mellitus and any other illness requiring long term treatment. 5. Pregnant or Lactating Women. 6. Significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction 7. Known cases of Immunocompromised states like HIV/ AIDS, etc. or Malignancies 8. Patient not willing to attend regular treatment and follow-up for the entire duration of study 9. Mentally retarded patients. 10. Patient having history of any surgery of nose or paranasal sinuses. 11. Patient having history of trauma to nose or sinus area. 12. Patient of pulmonary Koch’s or having history of epistaxis. 13. Any medical condition where physician feels that participation in the study could be detrimental to patient’s well- being. 14. Alcoholic and Drug addicted patient.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical assessment will be done and the response to treatment will be assessed using the following parameters: 1. Visual Analogue ScaleTimepoint: Week 2, 4 and 6. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Visual Analogue ScaleTimepoint: Week 2, 4 & 6. | — |
Countries
India
Contacts
Public ContactDr Usamah Ahmad
State Unani Medical College
Outcome results
None listed